Live stream preview

Next video will start in 30 seconds

OKYO Pharma: Next Generation Therapeutics for Inflammatory Eye Diseases

Close Open

1847 Holdings: Acquisitions and Spinoffs of Growing US-Based Businesses

Pitch Promotion • 2m 9s

Up Next in Pitch Promotion

  • OKYO Pharma: Next Generation Therapeu...

    OKYO Pharma (LSE: OKYO) is a biopharmaceutical company developing next generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. The Company is developing first in class drug candidates designed to prevent disease instead of controlling it. OKYO’s d...

  • Document Security Systems NYSE Americ...

    Document Security Systems (NYSE American: DSS) is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in wh...

  • 1847 Holdings LLC (OTC: EFSH) Acquisi...

    1847 Holdings LLC (OTC: EFSH) acquires and operates American companies it acquires at attractive valuations, leveraging its management team’s extensive experience gained at leading investment firms, such as Colony Capital, Lazard Freres and Saunders, Karp & Megrue, to grow operations and crea...